Study Examines Effects of Cranberries on Women’s UTI

April 19, 2011

The 90-day, randomized, double-blind, controlled study administered a daily dose of 500 mg of PACran.

Decas Botanical Synergies (Carver, MA) announced the publication of a study in Current Bioactive Compounds examining the effects of the company’s PACran cranberry supplement on women with recurring urinary tract infections (UTIs) and a confirmed presence of E. coli in the culture of urine samples.

The 90-day, randomized, double-blind, controlled study administered a daily dose of 500 mg of PACran. The company says that at the end of the treatment period, results showed a significant reduction in the presence of E. coli and support for urinary tract health.